Press Releases

Mar 25, 2021
Windtree Therapeutics Announces Closing of $30.0 Million Public Offering
WARRINGTON, Pa., March 25, 2021 / PRNewswire / -- Windtree Therapeutics, Inc. (NasdaqCM: WINT) ("Windtree" or the "Company"), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced the
Mar 23, 2021
Windtree Therapeutics Announces Pricing of $30.0 Million Public Offering
WARRINGTON, Pa., March 23, 2021 / PRNewswire / -- Windtree Therapeutics, Inc. (NasdaqCM: WINT) ("Windtree" or the "Company"), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced the
Mar 15, 2021
Windtree to Present at the Oppenheimer 31st Annual Healthcare Conference
WARRINGTON, Pa., March 15, 2021 / PRNewswire / -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that Craig Fraser, president and chief
Mar 8, 2021
Windtree to Present at the H.C. Wainwright Global Life Sciences Conference
WARRINGTON, Pa., March 8, 2021 / PRNewswire / -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on advancing multiple late-stage interventions for acute cardiovascular and pulmonary disorders, today announced that Craig Fraser, president and chief
Feb 4, 2021
Windtree Strengthens Its Board by Appointing Three New Directors
Company welcomes Dr. Evan Loh, Ms. Leslie Williams and Dr. Rob Scott, seasoned executives with deep cardiovascular development and commercial experience WARRINGTON, Pa., Feb. 4, 2021 / PRNewswire / -- Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused